Jatin Shah Karyopharm Therapeutics Inc. (KPTI) insider trading activity
Jatin Shah is EVP, Chief Medical Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 129,450 shares of KPTI, which is worth approximately $128,155. The most recent transaction as insider was on Feb 17, 2022, when has been sold 1,306 shares (Common Stock) at a price of $12.12 per share, resulting in proceeds of $15,829. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
129K
0%
3M change
0%
12M change
Total Value Held
$128,155
Jatin Shah Transaction History
JS
Jatin Shah
EVP, Chief Medical Officer
Newton, MA